risks of glp 1 agonists The promise and peril GLP-1 agonists: What we do (and don't) know as of August 2024 Adverse Effects of GLP-1 Receptor
Description
As mentioned, GLP-1RAs can reduce the content of systemic inflammation markers
1 With the possible exception of Operation Warp Speed, GLP-1 therapies have defined the decade in terms of impact on population health
veterans with type 2 diabetes for three years
What does the Gila monster have that we don't have
There is no clinical data on this combination, and it is generally not recommended because the GLP-1 receptor activation from multiple compounds would overlap, potentially increasing gastrointestinal side effects without proportional benefit
